Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares have beem adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2025-11-14 6:30 pm Sale | 2025-09-30 | 13G | Evotec SE EVO | Novo Holdings A/S | 9,407,883 5.300% | -5,523,975 (-36.99%) | Filing History |
| 2025-11-14 6:29 pm Sale | 2025-09-30 | 13G | Zenas BioPharma, Inc. ZBIO | Novo Holdings A/S | 2,000,000 4.700% | -214,967 (-9.71%) | Filing History |
| 2025-11-04 4:21 pm Purchase | 2025-10-28 | 13D | MapLight Therapeutics, Inc. MPLT | Novo Holdings A/S | 3,686,622 8.400% | 3,686,622 (New Position) | Filing History |
| 2025-10-20 5:12 pm Purchase | 2025-10-13 | 13G | 4D Molecular Therapeutics, Inc. FDMT | Novo Holdings A/S | 3,175,000 6.800% | 3,175,000 (New Position) | Filing History |
| 2025-10-09 4:29 pm Sale | 2025-10-07 | 13D | Galecto, Inc. GLTO | Novo Holdings A/S | 0 0.000% | -86,579 (Position Closed) | Filing History |
| 2025-09-25 4:49 pm Sale | 2025-09-23 | 13D | Galecto, Inc. GLTO | Novo Holdings A/S | 86,579 6.500% | -13,334 (-13.35%) | Filing History |
| 2025-08-19 5:09 pm Sale | 2025-08-11 | 13D | IO Biotech, Inc. IOBT | Novo Holdings A/S | 4,981,588 7.300% | -841,996 (-14.46%) | Filing History |
| 2025-08-14 4:59 pm Purchase | 2025-06-30 | 13G | ArriVent BioPharma, Inc. Common Stock AVBP | Novo Holdings A/S | 1,872,142 4.900% | 122,142 (+6.98%) | Filing History |
| 2025-04-01 9:47 pm Purchase | 2025-03-25 | 13G | Zenas BioPharma, Inc. ZBIO | Novo Holdings A/S | 2,214,967 5.300% | 2,214,967 (New Position) | Filing History |
| 2025-02-14 9:00 pm Purchase | 2025-02-07 | 13G | ArriVent BioPharma, Inc. Common Stock AVBP | Novo Holdings A/S | 1,750,000 5.200% | 1,750,000 (New Position) | Filing History |
| 2025-01-16 9:43 pm Purchase | 2024-08-29 | 13D | Galecto, Inc. GLTO | Novo Holdings A/S | 99,913 7.600% | 1 (+0.00%) | Filing History |
| 2024-11-22 9:11 pm Sale | 2024-11-20 | 13G | Exscientia plc EXAI | Novo Holdings A/S | 0 0.000% | -13,086,600 (Position Closed) | Filing History |
| 2024-09-23 9:20 pm Sale | 2024-09-19 | 13D | Edgewise Therapeutics, Inc. EWTX | Novo Holdings A/S | 5,549,900 5.900% | -794,530 (-12.52%) | Filing History |
| 2024-09-17 9:01 pm Sale | 2024-09-13 | 13D | IO Biotech, Inc. IOBT | Novo Holdings A/S | 5,823,584 8.500% | -1,075,000 (-15.58%) | Filing History |
| 2024-06-24 9:06 pm Unchanged | 2024-06-20 | 13D | Galecto, Inc. GLTO | Novo Holdings A/S | 99,912 9.200% | 0 (Unchanged) | Filing History |
| 2024-05-14 9:35 pm Sale | 2024-05-10 | 13G | IO Biotech, Inc. IOBT | Novo Holdings A/S | 6,898,584 10.100% | -658,809 (-8.72%) | Filing History |
| 2024-03-28 9:15 pm Sale | 2024-03-26 | 13D | Spruce Biosciences, Inc. SPRB | Novo Holdings A/S | 22,080 3.900% | -14,667 (-39.91%) | Filing History |
| 2024-03-25 9:48 pm Sale | 2024-03-21 | 13D | Spruce Biosciences, Inc. SPRB | Novo Holdings A/S | 36,747 6.400% | -25,534 (-41.00%) | Filing History |
| 2024-03-20 9:31 pm Sale | 2024-03-18 | 13D | Spruce Biosciences, Inc. SPRB | Novo Holdings A/S | 62,280 10.900% | -23,933 (-27.76%) | Filing History |
| 2024-03-18 9:16 pm Sale | 2024-03-14 | 13D | Spruce Biosciences, Inc. SPRB | Novo Holdings A/S | 86,214 15.100% | -25,498 (-22.82%) | Filing History |